About US
Contact us
-
Novo Nordisk to appeal against ruling in repaglinide combination patent caseToday, Novo Nordisk announced that Judge Avern Cohn of the US District Court for the Eastern District of Michigan issued an adverse ruling in a patent litigation case regarding Novo Nordisk's US Paten2011/1/21
-
Huanggang Winner receives State Development and Reform Commission's Cotton Processing CertificateWinner Medical Group Inc. a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton® products in China, today announced that one of its2011/1/21
-
Regeneron and Bayer Begin Retinal Disease Drug StudyRegeneron and Bayer HealthCare have initiated a Phase III clinical to evaluate the efficacy and safety of VEGF Trap-Eye (aflibercept ophthalmic solution) in patients with myopic choroidal neovasculari2011/1/20
-
Merck Serono and Domain to Develop Parkinson's DrugsMerck Serono and Domain Therapeutics have entered into a development and licensing agreement to develop positive allosteric modulators of metabotropic glutamate receptor 4 to treat for Parkinson's dis2011/1/20
-
Capsules with essential oils reduce symptoms of premenstrual syndromeA pill containing a mix of essential oils has been shown to significantly reduce the symptoms of premenstrual syndrome (PMS). Researchers writing in BioMed Central's open access journal Reproductive H2011/1/19
-
New Path to Destroy Breast Cancer Stem Cells FoundScientists at the University of Michigan Comprehensive Cancer Center in the US have identified a new 'indirect' route that could provide a means of targeting dangerous breast cancer stem cells. Res2011/1/19
-
DBA Announces New Name: NSF-DBADavid Begg Associates (DBA), an NSF International company with expertise in training, auditing and consultancy for the pharmaceutical and medical device industries, has changed its name to NSF-DBA. NS2011/1/18
-
Johnson & Johnson Sued Over Secret Motrin RecallJohnson & Johnson has been sued by the US State of Oregon following claims it secretly recalled defective painkiller Motrin, putting consumers at risk. Attorney general John Kroger claimed Joh2011/1/18
-
FDA Drug Safety Podcast: FDA Reduces Dose of Acetaminophen in Combination Prescription ProductsOn January 13, 2011, the Food and Drug Administration issued a drug safety communication announcing that all prescription combinations of opioids and acetaminophen can no longer contain more than 325m2011/1/17
-
ShangPharma opens new multi-purpose pharma development and cGMP manufacturing facility in FengxianShangPharma Corporation (NYSE:SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced commencement o2011/1/17